Aptinyx Reports Third Quarter 2022 Financial Results and Recent Highlights Nov 8, 2022 04:05PM
Aptinyx (APTX) Announces $5.6M NIH Grant to Evaluate NYX-783 Nov 3, 2022 07:33AM
Clinical Evaluation of Aptinyx's NYX-783 for Treatment of Opioid Use Disorder to Be Funded by $5.6 Million NIH Grant Nov 3, 2022 07:30AM
Aptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy Bodies Aug 25, 2022 07:30AM
Aptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights Aug 4, 2022 04:05PM


Jun 22, 2022 07:47AM Aptinyx to Participate in H.C. Wainwright 1st Annual Mental Health Conference
May 18, 2022 07:37AM Aptinyx to Participate in H.C. Wainwright Global Investment Conference
May 12, 2022 04:05PM Aptinyx Reports First Quarter 2022 Financial Results and Highlights Recent Clinical Progress
Feb 28, 2022 07:25AM Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Fibromyalgia
Feb 3, 2022 07:37AM Aptinyx Announces Formation of Scientific Advisory Board
Dec 16, 2021 07:37AM Aptinyx Initiates Phase 2b Study of NYX-783 in Patients with Post-Traumatic Stress Disorder
Nov 18, 2021 07:49AM Aptinyx to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
Nov 9, 2021 04:05PM Aptinyx Reports Third Quarter 2021 Financial Results and Recent Highlights
Oct 25, 2021 07:32AM Aptinyx to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
Oct 20, 2021 07:57AM Aptinyx (APTX) Appoints Gilmore O’Neill to its Board
Oct 20, 2021 07:57AM Aptinyx Appoints Gilmore O’Neill, M.B., M.M.Sc., to Board of Directors
Sep 20, 2021 07:57AM Aptinyx to Participate in 2021 Cantor Virtual Global Healthcare Conference
Sep 16, 2021 06:37AM Aptinyx Secures $50 Million Growth Capital Credit Facility from K2 HealthVentures
Aug 31, 2021 07:57AM Aptinyx to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
Aug 10, 2021 04:10PM Aptinyx Reports Second Quarter 2021 Financial Results and Business Highlights
Aug 3, 2021 07:57AM Aptinyx to Participate in 2021 Wedbush PacGrow Healthcare Virtual Conference
Jul 26, 2021 07:57AM Aptinyx to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021
Jun 15, 2021 04:10PM Aptinyx Provides Update on NYX-783 Development Program for the Treatment of Post-Traumatic Stress Disorder
May 13, 2021 04:05PM Aptinyx Reports First Quarter 2021 Financial Results and Highlights
May 10, 2021 07:57AM Aptinyx Appoints Joan W. Miller, M.D. to Board of Directors
Oct 21, 2020 09:27AM Pre-Open Stock Movers 10/21: (ASTC) (SNAP) (CALX) Higher; (GSX) (NAVI) (NFLX) Lower (more...)
Oct 20, 2020 05:33PM After-Hours Stock Movers 10/20: (ASTC) (SNAP) (PRTA) Higher; (NAVI) (NFLX) (APTX) Lower (more...)